Full year 2023 results: AU$0.008 loss per share (further deteriorated from AU $0.007 loss in FY 2022).
Revenue: AU$2.77m (down 18% from FY 2022).
Net loss: AU$3.76m (loss widened 37% from FY 2022).
As a shareholder I would be lying to say I am inspired however to sell at a 60 per cent loss on my single largest holding is something I am unable to stomach.
There are a number of products in the pipeline let's hope Greg and the team can make them work.
I am not sure how a capital raise would play out as they seem to have little ability to convert potential into actuality.
- Forums
- ASX - By Stock
- Ann: Appendix 4E and Financial Report Year Ended 30 June 2023
RNT
rent.com.au limited
Add to My Watchlist
7.69%
!
2.8¢

Full year 2023 results: AU$0.008 loss per share (further...
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
2.8¢ |
Change
0.002(7.69%) |
Mkt cap ! $23.88M |
Open | High | Low | Value | Volume |
2.7¢ | 2.8¢ | 2.6¢ | $15.05K | 559.7K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 279742 | 2.7¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
2.8¢ | 404426 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 330000 | 0.026 |
2 | 140000 | 0.025 |
2 | 51622 | 0.024 |
1 | 30000 | 0.021 |
1 | 1000000 | 0.019 |
Price($) | Vol. | No. |
---|---|---|
0.030 | 248500 | 5 |
0.031 | 200000 | 1 |
0.032 | 8574 | 1 |
0.033 | 28378 | 1 |
0.034 | 675028 | 4 |
Last trade - 13.05pm 27/06/2025 (20 minute delay) ? |
Featured News
RNT (ASX) Chart |
The Watchlist
PAR
PARADIGM BIOPHARMACEUTICALS LIMITED..
Paul Rennie, MD & Founder
Paul Rennie
MD & Founder
SPONSORED BY The Market Online